Investors Sell Aetna (AET) on Strength (AET)

Traders sold shares of Aetna (NYSE:AET) on strength during trading on Wednesday. $23.81 million flowed into the stock on the tick-up and $117.97 million flowed out of the stock on the tick-down, for a money net flow of $94.16 million out of the stock. Of all stocks tracked, Aetna had the 0th highest net out-flow for the day. Aetna traded up $0.13 for the day and closed at $177.34

A number of research analysts recently issued reports on AET shares. Jefferies Group reiterated a “hold” rating and set a $205.00 price objective on shares of Aetna in a report on Wednesday, January 31st. Cowen reiterated a “buy” rating and set a $212.00 price objective on shares of Aetna in a report on Tuesday, January 30th. Citigroup downgraded Aetna from a “buy” rating to a “neutral” rating and increased their price objective for the stock from $187.89 to $212.00 in a report on Wednesday, January 31st. Credit Suisse Group increased their price objective on Aetna from $200.00 to $208.00 and gave the stock a “neutral” rating in a report on Wednesday, January 31st. Finally, Zacks Investment Research upgraded Aetna from a “sell” rating to a “hold” rating in a report on Thursday, May 3rd. Eight analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Aetna has a consensus rating of “Buy” and a consensus target price of $196.36.

The company has a debt-to-equity ratio of 0.47, a current ratio of 0.73 and a quick ratio of 0.73. The company has a market cap of $58.01 billion, a price-to-earnings ratio of 17.96, a P/E/G ratio of 1.50 and a beta of 0.64.

Aetna (NYSE:AET) last posted its quarterly earnings results on Tuesday, May 1st. The company reported $3.19 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.97 by $0.22. The firm had revenue of $15.34 billion during the quarter, compared to the consensus estimate of $15.32 billion. Aetna had a return on equity of 21.42% and a net margin of 5.76%. The business’s revenue was up 1.1% compared to the same quarter last year. During the same period last year, the company earned $2.71 earnings per share. equities analysts forecast that Aetna will post 11.06 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 1st. Stockholders of record on Wednesday, July 25th will be given a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, July 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.13%. Aetna’s payout ratio is 20.28%.

Several institutional investors and hedge funds have recently added to or reduced their stakes in AET. Schwab Charles Investment Management Inc. lifted its position in shares of Aetna by 2.6% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 1,235,475 shares of the company’s stock valued at $222,868,000 after buying an additional 30,799 shares during the last quarter. Cerebellum GP LLC acquired a new stake in shares of Aetna in the fourth quarter valued at approximately $125,000. Flagship Harbor Advisors LLC acquired a new stake in shares of Aetna in the fourth quarter valued at approximately $305,000. Hermes Investment Management Ltd. lifted its position in shares of Aetna by 9.3% in the fourth quarter. Hermes Investment Management Ltd. now owns 8,801 shares of the company’s stock valued at $1,588,000 after buying an additional 746 shares during the last quarter. Finally, FNY Partners Fund LP acquired a new stake in shares of Aetna in the fourth quarter valued at approximately $2,976,000. 84.19% of the stock is owned by institutional investors.

Aetna Company Profile

Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply